| The multifaceted role of curcumin in cancer prevention and treatment MK Shanmugam, G Rane, MM Kanchi, F Arfuso, A Chinnathambi, ... Molecules 20 (2), 2728-2769, 2015 | 590 | 2015 |
| Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds MK Shanmugam, JH Lee, EZP Chai, MM Kanchi, S Kar, F Arfuso, ... Seminars in cancer biology 40, 35-47, 2016 | 249 | 2016 |
| Art therapy is associated with sustained improvement in cognitive function in the elderly with mild neurocognitive disorder: findings from a pilot randomized controlled trial … R Mahendran, M Gandhi, RB Moorakonda, J Wong, MM Kanchi, J Fam, ... Trials 19, 1-10, 2018 | 118 | 2018 |
| Tocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics MM Kanchi, MK Shanmugam, G Rane, G Sethi, AP Kumar Drug discovery today 22 (12), 1765-1781, 2017 | 87 | 2017 |
| Prediction of m6A and m5C at single-molecule resolution reveals a transcriptome-wide co-occurrence of RNA modifications EE P Acera Mateos, A J Sethi, A Ravindran, A Srivastava, K Woodward, S ... Nature communications 15 (1), 3899, 2024 | 53* | 2024 |
| PPARγ ligand–induced annexin A1 expression determines chemotherapy response via deubiquitination of death domain kinase RIP in triple-negative breast cancers L Chen, Y Yuan, S Kar, MM Kanchi, S Arora, JE Kim, PF Koh, E Yousef, ... Molecular Cancer Therapeutics 16 (11), 2528-2542, 2017 | 40 | 2017 |
| Association between leukocyte telomere length and plasma homocysteine in a Singapore Chinese population G Rane, WP Koh, MM Kanchi, R Wang, JM Yuan, X Wang Rejuvenation research 18 (3), 203-210, 2015 | 35 | 2015 |
| Displacement of p130Cas from focal adhesions links actomyosin contraction to cell migration H Machiyama, H Hirata, XK Loh, MM Kanchi, H Fujita, SH Tan, ... Journal of cell science 127 (16), 3440-3450, 2014 | 32 | 2014 |
| The functional and structural connectomes of telomere length and their association with cognition in mild cognitive impairment J Yu, MM Kanchi, I Rawtaer, L Feng, AP Kumar, EH Kua, R Mahendran Cortex 132, 29-40, 2020 | 17 | 2020 |
| Differences between multimodal brain-age and chronological-age are linked to telomere shortening J Yu, MM Kanchi, I Rawtaer, L Feng, AP Kumar, EH Kua, R Mahendran, ... Neurobiology of Aging 115, 60-69, 2022 | 11 | 2022 |
| The use of transformed IMR90 cell model to identify the potential extra-telomeric effects of hTERT in cell migration and DNA damage response X Cao, CM Kong, KM Mathi, YP Lim, V Cacheux-Rataboul, X Wang BMC biochemistry 15, 1-9, 2014 | 6 | 2014 |
| Biochemical-free enrichment or depletion of RNA classes in real-time during direct RNA sequencing with RISER NSEE Alexandra Sneddon, Agin Ravindran, Somasundhari Shanmuganandam, Madhu ... Nature Communications 15, 4422, 2024 | 3 | 2024 |
| Abstract P6-18-20: Targeting mitochondrial function for the treatment of triple negative breast cancer: Development of a small molecule inhibitor against mitochondrial STAT3 MM Kanchi, JL Hirpara, K Sachaphibulkij, TZ Tan, H Dietzel, LH Lim, ... Cancer Research 79 (4_Supplement), P6-18-20-P6-18-20, 2019 | 2 | 2019 |
| Substrate diversity of NSUN enzymes and links of 5-methylcytosine to mRNA translation and turnover M Guarnacci, PH Zhang, M Kanchi, YT Hung, H Lin, NE Shirokikh, L Yang, ... Life Science Alliance 7 (9), 2024 | 1 | 2024 |
| Corrigendum to" Tocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics"[Drug Discov. Today 22 (December (12))(2017) 1765-1781] MM Kanchi, MK Shanmugam, G Rane, G Sethi, AP Kumar Drug discovery today 24 (7), 1421, 2019 | | 2019 |
| PO-462 Investigating the potential anti-cancer properties of a novel src family kinase inhibitor in triple negative breast cancer HC Leong, MM Kanchi, SM Kumaraswarmy, TZ Tan, V Pandey, ... ESMO Open 3, A203-A204, 2018 | | 2018 |
